Sarah Warner

1.8k total citations · 1 hit paper
33 papers, 933 citations indexed

About

Sarah Warner is a scholar working on Applied Microbiology and Biotechnology, Epidemiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Sarah Warner has authored 33 papers receiving a total of 933 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Applied Microbiology and Biotechnology, 10 papers in Epidemiology and 7 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Sarah Warner's work include Antibiotic Use and Resistance (13 papers), Sepsis Diagnosis and Treatment (8 papers) and Antibiotic Resistance in Bacteria (7 papers). Sarah Warner is often cited by papers focused on Antibiotic Use and Resistance (13 papers), Sepsis Diagnosis and Treatment (8 papers) and Antibiotic Resistance in Bacteria (7 papers). Sarah Warner collaborates with scholars based in United States, Canada and Singapore. Sarah Warner's co-authors include Sameer S. Kadri, Ahmed Babiker, Michael Klompas, Jeffrey R. Strich, Robert L. Danner, Yi Ling Lai, John P. Dekker, Junfeng Sun, Cumhur Y. Demirkale and Ning Rosenthal and has published in prestigious journals such as JAMA, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Sarah Warner

32 papers receiving 915 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risk Factors for Severe COVID-19 Outcomes Among Persons Aged ≥18 Years Who Completed a Primary COVID-19 Vaccination Series — 465 Health Care Facilities, United States, December 2020–October 2021

2022 135 citations Christina Yek, Sarah Warner et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah Warner United States	14	273	220	187	168	149	33	933
Kyung Mok Sohn South Korea	14	678 2.5×	191 0.9×	289 1.5×	51 0.3×	90 0.6×	39	1.1k
Jason N. Barreto United States	18	290 1.1×	134 0.6×	397 2.1×	78 0.5×	113 0.8×	56	1.1k
Christine Lawrence France	17	273 1.0×	281 1.3×	136 0.7×	61 0.4×	65 0.4×	45	843
Je Eun Song South Korea	15	163 0.6×	87 0.4×	306 1.6×	69 0.4×	60 0.4×	58	886
Kentaro Iwata Japan	12	135 0.5×	53 0.2×	181 1.0×	78 0.5×	36 0.2×	56	622
O. Celhay France	14	68 0.2×	118 0.5×	97 0.5×	84 0.5×	37 0.2×	41	780
Gunnar Jacobsson Sweden	19	564 2.1×	272 1.2×	475 2.5×	80 0.5×	296 2.0×	43	1.2k
Menno M. van der Eerden Netherlands	20	266 1.0×	118 0.5×	794 4.2×	103 0.6×	35 0.2×	43	1.4k
Noriko Kinoshita Japan	18	346 1.3×	126 0.6×	317 1.7×	120 0.7×	19 0.1×	71	1.1k
Yilun Sun United States	20	294 1.1×	207 0.9×	425 2.3×	18 0.1×	111 0.7×	55	1.1k

Countries citing papers authored by Sarah Warner

Since Specialization

Citations

This map shows the geographic impact of Sarah Warner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Warner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Warner more than expected).

Fields of papers citing papers by Sarah Warner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Warner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Warner. The network helps show where Sarah Warner may publish in the future.

Co-authorship network of co-authors of Sarah Warner

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Warner. A scholar is included among the top collaborators of Sarah Warner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Warner. Sarah Warner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yek, Christina, Guoqing Diao, Morgan Walker, et al.. (2025). Impact of the COVID-19 Pandemic on Antibiotic Resistant Infection Burden in U.S. Hospitals. Annals of Internal Medicine. 178(6). 796–807. 4 indexed citations

Powers, John H., Sameer S. Kadri, Sarah Warner, et al.. (2025). Demographics, epidemiology, mortality and difficult-to-treat resistance patterns of bacterial bloodstream infections in the global US Military Health System from 2010 to 2019: a retrospective cohort study. BMJ Open. 15(3). e094861–e094861.

Neupane, Maniraj, Sarah Warner, Junfeng Sun, et al.. (2024). Association Between Hospital Type and Resilience During COVID-19 Caseload Stress. Annals of Internal Medicine. 177(10). 1370–1380. 3 indexed citations

Strich, Jeffrey R., Guoqing Diao, Alexander Lawandi, et al.. (2024). Assessing Clinician Utilization of Next-Generation Antibiotics Against Resistant Gram-Negative Infections in U.S. Hospitals. Annals of Internal Medicine. 177(5). 559–572. 9 indexed citations

Walker, Morgan, Guoqing Diao, Sarah Warner, et al.. (2024). Carbapenem use in extended-spectrum cephalosporin-resistant Enterobacterales infections in US hospitals and influence of IDSA guidance: a retrospective cohort study. The Lancet Infectious Diseases. 24(8). 856–867. 3 indexed citations

Babiker, Ahmed, Sarah Warner, Xiaobai Li, et al.. (2024). Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation. The Lancet Infectious Diseases. 25(3). 265–275. 6 indexed citations

Kam, Kai‐Qian, Tom Chen, Sameer S. Kadri, et al.. (2024). Epidemiology and Outcomes of Antibiotic De-escalation in Patients With Suspected Sepsis in US Hospitals. Clinical Infectious Diseases. 80(1). 108–117. 4 indexed citations

Yek, Christina, Ning Rosenthal, Alex Kartashov, et al.. (2024). Trends in Patient Transfers From Overall and Caseload-Strained US Hospitals During the COVID-19 Pandemic. JAMA Network Open. 7(2). e2356174–e2356174. 6 indexed citations

Rhee, Chanu, Tom Chen, Sameer S. Kadri, et al.. (2024). Trends in Empiric Broad-Spectrum Antibiotic Use for Suspected Community-Onset Sepsis in US Hospitals. JAMA Network Open. 7(6). e2418923–e2418923. 19 indexed citations

10.

Hatfield, Kelly M, James Baggs, Sarah Warner, et al.. (2023). Assessment of Hospital-Onset SARS-CoV-2 Infection Rates and Testing Practices in the US, 2020-2022. JAMA Network Open. 6(8). e2329441–e2329441. 10 indexed citations

11.

Strich, Jeffrey R., Alexander Lawandi, Sarah Warner, et al.. (2023). Association between piperacillin/tazobactam MIC and survival among hospitalized patients with Enterobacterales infections: retrospective cohort analysis of electronic health records from 161 US hospitals. JAC-Antimicrobial Resistance. 5(2). dlad041–dlad041. 5 indexed citations

12.

Kadri, Sameer S., Sarah Warner, Chanu Rhee, et al.. (2023). Early Discontinuation of Antibiotics in Patients Admitted With Clinically Suspected Serious Infection but Negative Cultures: Retrospective Cohort Study of Practice Patterns and Outcomes at 111 US Hospitals. Open Forum Infectious Diseases. 10(7). ofad286–ofad286. 1 indexed citations

13.

Yek, Christina, Jing Wang, Jonathan Fintzi, et al.. (2023). Impact of Surge Strain and Pandemic Progression on Prognostication by an Established COVID-19–Specific Severity Score. Critical Care Explorations. 5(12). e1021–e1021. 3 indexed citations

14.

Brusca, Samuel B., Sarah Warner, Xiaobai Li, et al.. (2022). Outcomes of Patients With Primary Cardiac Diagnoses Admitted to Cardiac vs Noncardiac Intensive Care Units. JACC Advances. 1(4). 100114–100114. 3 indexed citations

15.

Babiker, Ahmed, Xiaobai Li, Yi Ling Lai, et al.. (2020). Effectiveness of adjunctive clindamycin in β-lactam antibiotic-treated patients with invasive β-haemolytic streptococcal infections in US hospitals: a retrospective multicentre cohort study. The Lancet Infectious Diseases. 21(5). 697–710. 55 indexed citations

16.

Kadri, Sameer S., Yi Ling Lai, Sarah Warner, et al.. (2020). Inappropriate empirical antibiotic therapy for bloodstream infections based on discordant in-vitro susceptibilities: a retrospective cohort analysis of prevalence, predictors, and mortality risk in US hospitals. The Lancet Infectious Diseases. 21(2). 241–251. 162 indexed citations

17.

Strich, Jeffrey R., Sarah Warner, Yi Ling Lai, et al.. (2020). Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study. The Lancet Infectious Diseases. 20(10). 1172–1181. 25 indexed citations

18.

Galasso, Marco, Paola Dama, Maurizio Previati, et al.. (2014). A large scale expression study associates uc.283-plus lncRNA with pluripotent stem cells and human glioma. Genome Medicine. 6(10). 76–76. 30 indexed citations

19.

Meng, Wei, Joseph P. McElroy, Stefano Volinia, et al.. (2013). Comparison of MicroRNA Deep Sequencing of Matched Formalin-Fixed Paraffin-Embedded and Fresh Frozen Cancer Tissues. PLoS ONE. 8(5). e64393–e64393. 65 indexed citations

20.

Elgar, Greg, Melody S. Clark, Stephen Meek, et al.. (1999). Generation and Analysis of 25 Mb of Genomic DNA from the Pufferfish Fugu rubripes by Sequence Scanning. Genome Research. 9(10). 960–971. 70 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact